Lymphoma Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who have been diagnosed with follicular lymphoma (a type of slow-growing blood cancer), grades 1, 2, or 3a, confirmed by lab testing at the NCI
• People whose disease can be seen and measured on CT or PET scans — this includes scans taken at any point since diagnosis, not only the most recent one
• People who have enough tissue available from their original diagnosis biopsy (if the biopsy was taken more than 12 months ago or enough tissue is not available, a repeat biopsy may optionally be done; the trial's lead doctor makes the final decision on this)
• People aged 18 or older
• People who are generally well enough to carry out daily activities, as measured by standard medical scoring (confirm with trial site)

Who may not be able to join:

• People who have previously had a more aggressive form of lymphoma called diffuse large B-cell lymphoma, or whose lymphoma has transformed into a more aggressive type
• People who have already received systemic treatment (such as chemotherapy, biological therapy, or monoclonal antibody therapy) for lymphoma — though prior radiation therapy is permitted; people treated for a different cancer (not lymphoma) may still be considered if that treatment ended at least 3 years before their follicular lymphoma diagnosis and there is no sign of that other cancer returning
• People who are HIV-positive
• People who have another cancer currently requiring active treatment
• People with another serious, life-threatening illness unrelated to lymphoma
• People who are not able to give their own informed consent to take part
• People who are currently pregnant (if a participant becomes pregnant during the study, invasive procedures would be paused to avoid risk to the unborn baby)

Important: Always verify eligibility with the trial site directly before applying.